Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

530 trials

NCT05918640
Recruiting
Lurbinectedin in FET-Fused Tumors
Phase 1/2 · United States · 6 sites
Registry update: 2 Sept 2026
NCT05837767
Recruiting
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
Not applicable · United States · 7 sites
Registry update: 2 Sept 2026
NCT06126510
Recruiting
Clinical Study of VG161 in the Treatment of Advanced Bone and Soft Tissue Sarcoma
Phase 2 · China · 1 site
Registry update: 24 Dec 2024
NCT05735184
Recruiting
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Phase 1 · United States · 44 sites
Registry update: 13 Mar 2026
NCT05894018
Recruiting
Brachytherapy (Iodine-125 Seeds) and Fluzoparib Combination Therapy for Advanced Unresectable Soft Tissue Sarcoma
Phase 2 · China · 1 site
Registry update: 13 May 2025
NCT05910307
Recruiting
Synovial Sarcoma Registry / Biospecimen Repository
Not applicable · United States · 1 site
Registry update: 9 Jun 2026
NCT05830123
Recruiting
ARTEMIS-002: HS-20093 in Patients With Relapsed or Refractory Osteosarcoma and Other Sarcomas
Phase 2 · China · 11 sites
Registry update: 23 Aug 2024
NCT06114225
Recruiting
Pulmonary Resectable Osteosarcoma Treated by Metastasectomy and Pre-operative Immunotherapy and Stereotactic Body Radiotherapy (PROMIS): a Prospective Clinical Trial
Phase 2 · China · 1 site
Registry update: 2 Nov 2023
NCT06074692
Recruiting
PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic or Advanced Sarcoma (PRIMA)
Phase 2 · China · 1 site
Registry update: 31 Oct 2023
NCT05824975
Recruiting
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
Phase 1/2 · South Korea, United States · 10 sites
Registry update: 25 Nov 2024
NCT05732831
Recruiting
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Phase 1/2 · Spain, France, United States · 26 sites
Registry update: 8 Sept 2026
NCT05861245
Recruiting
Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull Base
Not applicable · Spain · 1 site
Registry update: 23 Jan 2026
NCT05734066
Recruiting
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
Phase 1/2 · Canada, United States · 16 sites
Registry update: 5 Nov 2026
NCT05890781
Recruiting
Engineering Immune Organoids to Study Pediatric Cancer
Not applicable · France · 2 sites
Registry update: 9 Feb 2026
NCT05672108
Recruiting
Phase II Trial of Lung Chemoemobolization
Phase 2 · United States · 2 sites
Registry update: 5 Mar 2026
NCT05663502
Recruiting
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
Not applicable · United States · 8 sites
Registry update: 1 Jun 2026
NCT05859074
Recruiting
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
Phase 1 · United States · 7 sites
Registry update: 12 Aug 2026
NCT05588648
Recruiting
Study to Assess Safety and Efficacy of Vactosertib in Adolescents and Adults With Recurrent, Refractory or Progressive Osteosarcoma
Phase 1/2 · South Korea, United States · 7 sites
Registry update: 7 Oct 2026
NCT05617859
Recruiting
Lenvatinib for Advanced Bone and Soft Tissue Sarcoma
Phase 2 · China · 1 site
Registry update: 21 Aug 2023
NCT06508307
Recruiting
A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors
Phase 1 · China · 1 site
Registry update: 21 Aug 2025

Ordered by registry start date. Freshness and sponsorship never change the order.